Mid-size pharmaceuticals market to reach $1059.05 billion by 2030 at 7.0% CAGR, driven by increased prevalence of chronic diseases.
Read More
Microtubule inhibitor chemotherapy drugs market to reach $7.23 billion by 2030 at 5.8% CAGR, driven by increasing prevalence of cancer.
Read More
Microcarrier beads market to reach $4.95 billion by 2030 at 8.9% CAGR, driven by growing trend of personalized medicine.
Read More
The global microcarrier market to reach $4.15 billion by 2030 at 12.0% CAGR, driven by increasing prevalence of cancer cases.
Read More
The global microbiome market to reach $1.64 billion by 2030 at 15.0% CAGR, driven by rising healthcare expenditure.
Read More
Microbiology technology, equipment and consumables market to reach $13.24 billion by 2030 at 11.3% CAGR, driven by increasing hospital-acquired infection rates.
Read More
Microbial sealant market to reach $4.16 billion by 2030 at 8.1% CAGR, driven by increasing number of surgeries and surging number of sports injuries.
Read More
Microbial api market to reach $95.49 billion by 2030 at 7.0% CAGR, driven by rising prevalence of chronic conditions.
Read More
Mexiletine hydrochloride market to reach $1.93 billion by 2030 at 8.4% CAGR, driven by increasing number of cardiovascular diseases.
Read More
Metronidazole market to reach $0.8 billion by 2030 at 5.5% CAGR, driven by increasing incidence of bacterial infections.
Read More